Detalles de la búsqueda
1.
Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.
J Pharmacol Exp Ther
; 336(2): 468-78, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21036913
2.
KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Mol Pharmacol
; 76(1): 153-62, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19364813
3.
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
J Med Chem
; 53(21): 7739-55, 2010 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20931971
4.
Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
J Med Chem
; 52(9): 3047-62, 2009 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19374401
5.
Inhibition of inducible nitric oxide synthase expression by a novel small molecule activator of the unfolded protein response.
Curr Chem Genomics
; 2: 1-9, 2008 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-20161838
6.
Time-of-flight optophoresis analysis of live whole cells in microfluidic channels.
Biomed Microdevices
; 6(1): 11-21, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15307440
Resultados
1 -
6
de 6
1
Próxima >
>>